Cargando…
State of the Art in 2022 PET/CT in Breast Cancer: A Review
Molecular imaging with positron emission tomography is a powerful and well-established tool in breast cancer management. In this review, we aim to address the current place of the main PET radiopharmaceuticals in breast cancer care and offer perspectives on potential future radiopharmaceutical and t...
Autor principal: | Zhang-Yin, Jules |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917740/ https://www.ncbi.nlm.nih.gov/pubmed/36769616 http://dx.doi.org/10.3390/jcm12030968 |
Ejemplares similares
-
What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
por: Zhang-Yin, Jules Tianyu, et al.
Publicado: (2022) -
PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art
por: Razik, Abdul, et al.
Publicado: (2018) -
The Role of PET/CT in Breast Cancer
por: Hadebe, Bawinile, et al.
Publicado: (2023) -
Feasibility of state of the art PET/CT systems performance harmonisation
por: Kaalep, Andres, et al.
Publicado: (2018) -
State of the art in total body PET
por: Vandenberghe, Stefaan, et al.
Publicado: (2020)